Position in TBPH
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$414,189
-$797,657 QoQ
Shares Held
25,520
-60.6% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WINTON GROUP Ltd holds $78,150,524 across 71 Biotechnology names. TBPH ranks #32 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
173,032 | $16,285,771 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,778 | $11,418,073 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
106,532 | $7,999,487 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
47,925 | $3,558,910 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
55,080 | $3,453,516 | |
| 6 | VIR |
Vir Biotechnology, Inc.
|
367,883 | $3,296,231 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
307,096 | $2,892,844 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
60,457 | $1,674,658 |
All Filings in TBPH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $414,189 | 25,520 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,211,846 | 64,770 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,117,513 | 76,542 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||